Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mencevax ACW135 Safety and Immunogenicity in Ethiopians
NCT00994695Phase 2Completed
- Sponsor
- Armauer Hansen Research Institute
- Start
- Nov 2005
- Primary completion
- Jan 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Mencevax ACW in meningococcal meningitis, sponsored by Armauer Hansen Research Institute. Started Nov 2005; status: completed.
02
Drugs
Mencevax ACW
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT00994695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994695.